# HEPA (Hepion Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Hepion Pharmaceuticals, Inc. reported $5.01M in total assets and a net loss of $7.30M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/HEPA
- Markdown: https://convexityos.com/fundamentals/HEPA.md
- SEC CIK: 0001583771
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:13 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001583771&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$4.17M | Operating profit |
| Net Income | FY 2025 | -$7.30M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.10 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $4.26M | Total debt: $370K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | $0 | $0 | $0 | $0 | -- | -- | -- | -- |
| Research & Development | $446K | $11.85M | $35.64M | $33.27M | $20.40M | $12.00M | $3.18M | $7.59M | $13.37M | $13.65M |
| Total Operating Expenses | $4.16M | $19.35M | $48.45M | $45.49M | $30.40M | $20.15M | $7.77M | $14.59M | -- | $21.02M |
| **Operating Income** | -$4.16M | -$19.35M | -$48.45M | -$45.49M | -$30.40M | -$20.15M | -$7.77M | -$14.59M | -$20.65M | -$21.02M |
| **EBITDA** | -- | -$19.32M | -$48.38M | -$45.41M | -$30.32M | -$20.11M | -$7.74M | -$14.58M | -- | -$21.00M |
| Interest Expense | -- | -- | $9.5K | $10K | $8.9K | $31K | $555K | $339K | -- | -- |
| Income Before Tax | -$8.28M | -$16.16M | -$49.34M | -$45.08M | -$32.72M | -$20.32M | -$7.95M | -$9.99M | -$15.03M | -$16.80M |
| Income Tax Expense | -- | -$2.97M | -$409K | -$2.88M | $0 | $31K | -$909K | -$536K | -$1.95M | -$1.91M |
| **Net Income** | -$8.28M | -$13.19M | -$48.93M | -$42.20M | -$32.72M | -$20.35M | -$7.04M | -$9.45M | -$13.08M | -$14.89M |
| Basic EPS | -$0.88 | -$107.35 | -$616.07 | -$595.00 | -$940.00 | -$4,200.00 | -$11,900.00 | -$194,700.00 | -- | -$285,314.69 |
| **Diluted EPS** | -$0.88 | -$107.35 | -$616.07 | -$595.00 | -$940.00 | -$4,200.00 | -$12,220.00 | -$194,405.59 | -- | -$337,062.94 |
| Basic Shares Outstanding | 9.4M | 122.9K | 79.4K | 76.2K | 35.1K | 4.8K | 1.0K | 92 | 69 | 52 |
| Diluted Shares Outstanding | 9.4M | 122.9K | 79.4K | 76.2K | 35.1K | 4.8K | 1.0K | 92 | 69 | 52 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $135K | $51K | $70K | $0 | $0 | $423K | $22K | -$592K |
| Total Operating Expenses | $1.55M | $1.21M | $799K | $610K | $528K | $1.75M | $1.28M | $1.20M |
| **Operating Income** | -$1.55M | -$1.21M | -$799K | -$610K | -$528K | -$1.75M | -$1.28M | -$1.20M |
| **EBITDA** | -- | -- | -- | -- | -- | -- | -- | -$1.20M |
| Income Before Tax | -- | -- | -- | -$657K | -$473K | -$1.04M | -$6.11M | -$1.55M |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Net Income** | -$4.58M | -$1.25M | -$811K | -$657K | -$473K | -$1.04M | -$6.11M | -$1.55M |
| Basic EPS | -$0.06 | -$0.08 | -$0.07 | -- | -$0.04 | -$0.09 | -$2.15 | -- |
| **Diluted EPS** | -$0.06 | -$0.08 | -$0.07 | -- | -$0.04 | -$0.09 | -$2.15 | -- |
| Basic Shares Outstanding | 71.1M | 16.2M | 11.6M | -- | 11.6M | 11.3M | 2.8M | -- |
| Diluted Shares Outstanding | 71.1M | 16.2M | 11.6M | -- | 11.6M | 11.3M | 2.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.83M | $406K | $14.79M | $51.19M | $91.35M | $40.73M | $13.92M | $2.83M | $5.95M | $12.98M |
| **Cash & Short-Term Investments** | $1.83M | $406K | $14.79M | $51.19M | $91.35M | $40.73M | $13.92M | $2.83M | $5.95M | $12.98M |
| **Total Current Assets** | $3.07M | $1.61M | $17.49M | $56.50M | $97.45M | $42.63M | $14.39M | $2.97M | $6.06M | $13.19M |
| Property, Plant & Equipment, Net | -- | -- | $29K | $82K | $153K | $108K | $57K | $32K | $57K | $68K |
| Goodwill | -- | -- | -- | $0 | $1.87M | $1.87M | $1.87M | $1.87M | $1.87M | $1.87M |
| Other Non-Current Assets | -- | -- | $364K | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $0 | $0 | $607K | $3.75M | $6.10M | $6.01M | $6.22M | $5.22M | $5.19M | $5.19M |
| **Total Assets** | $3.07M | $1.61M | $18.09M | $60.24M | $103.6M | $48.65M | $20.61M | $8.19M | $11.25M | $18.38M |
| Accounts Payable | $168K | $220K | $2.35M | $2.67M | $2.45M | $3.72M | $492K | $748K | $1.56M | $1.63M |
| Short-Term Debt | -- | -- | -- | -- | -- | $0 | -- | -- | -- | -- |
| **Total Current Liabilities** | $299K | $3.14M | $5.29M | $7.89M | $8.21M | $4.66M | $1.61M | $2.85M | $2.60M | $2.94M |
| **Total Non-Current Liabilities** | $103K | $333K | $5.52M | $2.50M | $2.35M | $3.46M | $3.39M | $3.36M | $4.95M | $6.38M |
| **Total Liabilities** | $402K | $3.48M | $10.81M | $10.39M | $10.56M | $8.12M | $4.99M | $6.21M | $7.55M | $9.33M |
| **Total Debt (incl. Leases)** | -- | -- | $209K | $54K | $317K | $576K | $807K | -- | -- | -- |
| Common Stock | $1.2K | $14 | $10 | $381 | $7.6K | $3.2K | $375 | $25 | $979 | $7.6K |
| Retained Earnings | -$246.1M | -$237.8M | -$224.6M | -$175.7M | -$133.5M | -$104.1M | -$83.75M | -$76.71M | -$67.01M | -$59.50M |
| Accumulated Other Comp. Income | $8.3K | $8.3K | -$79K | -$90K | $0 | -- | -- | -- | -- | -- |
| **Total Stockholders' Equity** | $2.67M | -$1.86M | $7.28M | $49.86M | $93.00M | $40.52M | $15.62M | $1.72M | $3.70M | $9.06M |
| Total Equity | $2.67M | -$1.86M | $7.28M | $49.86M | $93.00M | $40.52M | $15.62M | $1.72M | $3.70M | $9.06M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.26M | $1.63M | $2.60M | $1.83M | $2.32M | $2.92M | $4.59M | $406K |
| **Cash & Short-Term Investments** | $4.26M | $1.63M | $2.60M | $1.83M | $2.32M | $2.92M | $4.59M | $406K |
| **Total Current Assets** | $4.94M | $1.93M | $2.71M | $3.07M | $3.74M | $4.51M | $6.32M | $1.61M |
| Other Non-Current Assets | $2.0K | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $63K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Assets** | $5.01M | $1.93M | $2.71M | $3.07M | $3.74M | $4.51M | $6.32M | $1.61M |
| Accounts Payable | $161K | $170K | $138K | $168K | $77K | $173K | $243K | $220K |
| Short-Term Debt | $300K | -- | -- | -- | -- | -- | -- | -- |
| Other Current Liabilities | -- | -- | $250K | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $1.11M | $493K | $736K | $299K | $347K | $593K | $936K | $3.14M |
| **Total Non-Current Liabilities** | $7.91M | $156K | $113K | $103K | $68K | $116K | $1.49M | $333K |
| **Total Liabilities** | $9.02M | $649K | $849K | $402K | $416K | $709K | $2.42M | $3.48M |
| **Total Debt (incl. Leases)** | $370K | -- | -- | -- | -- | -- | -- | -- |
| Common Stock | $10K | $2.9K | $1.2K | $1.2K | $1.2K | $1.2K | $959 | $14 |
| Retained Earnings | -$252.7M | -$248.2M | -$246.9M | -$246.1M | -$245.4M | -$245.0M | -$243.9M | -$237.8M |
| Accumulated Other Comp. Income | $8.3K | $8.3K | $8.3K | $8.3K | $8.3K | $8.3K | $8.3K | $8.3K |
| **Total Stockholders' Equity** | -$4.02M | $1.28M | $1.86M | $2.67M | $3.32M | $3.80M | $3.90M | -$1.86M |
| Total Equity | -$4.02M | $1.28M | $1.86M | $2.67M | $3.32M | $3.80M | $3.90M | -$1.86M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$8.28M | -$13.19M | -$48.93M | -$42.20M | -$32.72M | -$20.35M | -$7.04M | -$9.45M | -$14.89M | -$17.00M |
| Depreciation & Amortization | -- | $31K | $67K | $77K | $86K | $35K | $27K | $19K | $28K | $22K |
| Stock-Based Compensation | $21K | $792K | $1.34M | $2.55M | $4.67M | $2.38M | $66K | $235K | $1.70M | $902K |
| **Operating Cash Flow** | -$3.27M | -$18.22M | -$40.89M | -$34.96M | -$31.22M | -$16.17M | -$7.57M | -$15.65M | -$19.17M | -$16.56M |
| Capital Expenditure | -- | -- | -$14K | -$16K | -$130K | -$88K | -$51K | -- | -$15K | -$6.6K |
| **Free Cash Flow** | -- | -- | -$40.90M | -$34.98M | -$31.35M | -$16.25M | -$7.62M | -- | -$19.19M | -$16.56M |
| Acquisitions, Net | -- | -- | -- | -- | -- | -- | -- | -- | -- | -$496K |
| Purchases of Investments | -$132K | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | -$132K | -$600K | -$14K | -$14K | -$130K | -$86K | -$51K | $900 | -$15K | -$502K |
| Common Stock Issued | $9.00M | $1.85M | $4.49M | $0 | $82.15M | $42.87M | $7.68M | $1.64M | $24.66M | $19.86M |
| **Financing Cash Flow** | $4.83M | $4.35M | $4.49M | -$5.14M | $81.98M | $43.05M | $18.71M | $12.52M | $24.77M | $19.90M |
| **Net Change in Cash** | $1.42M | -$14.38M | -$36.40M | -$40.16M | $50.62M | $26.80M | $11.09M | -$3.12M | $5.58M | $2.84M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$4.58M | -$1.25M | -$811K | -$657K | -$473K | -$1.04M | -$6.11M | -$1.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- | -- | -- | $0 |
| Stock-Based Compensation | -- | -- | -- | $0 | $0 | $0 | $21K | $29K |
| **Operating Cash Flow** | -$882K | -$1.39M | $579K | -$333K | -$446K | -$1.38M | -$1.12M | -$1.15M |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | $0 |
| Common Stock Issued | -- | -- | -- | $0 | $0 | $0 | $9.00M | $0 |
| **Financing Cash Flow** | $4.01M | $420K | $196K | -$160K | -$157K | -$155K | $5.30M | $0 |
| **Net Change in Cash** | $2.63M | -$974K | $775K | -$493K | -$603K | -$1.66M | $4.18M | -$1.09M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -310.3% | -- | -672.0% | -84.6% | -35.2% | -50.2% | -45.1% | -547.9% | -353.2% | -164.4% |
| Return on Assets (ROA) | -269.6% | -817.5% | -270.4% | -70.0% | -31.6% | -41.8% | -34.1% | -115.4% | -116.2% | -81.0% |
| Current Ratio | 10.25x | 0.51x | 3.31x | 7.16x | 11.88x | 9.15x | 8.94x | 1.04x | 2.33x | 4.48x |
| Quick Ratio | 6.11x | 0.13x | 2.80x | 6.49x | 11.13x | 8.74x | 8.65x | 0.99x | 2.29x | 4.41x |
| Debt to Equity | -- | -- | 0.03x | 0.00x | 0.00x | 0.01x | 0.05x | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -249.4% | -160.6% | -310.3% | -275.8% | -357.2% | -422.1% | -- |
| Return on Assets (ROA) | -145.8% | -165.4% | -110.2% | -269.6% | -245.1% | -301.0% | -260.3% | -817.5% |
| Current Ratio | 4.43x | 3.91x | 3.68x | 10.25x | 10.77x | 7.60x | 6.75x | 0.51x |
| Quick Ratio | 3.82x | 3.31x | 3.54x | 6.11x | 6.68x | 4.93x | 4.90x | 0.13x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
